PHARMACEUTICAL COMPOSITION INTENDED FOR APPLICATION FOR PREVENTION AND / OR TREATMENT OF A DISEASE THAT IS DEVELOPING OR PROGRESSING AS A RESULT OF REDUCTION OR LOSS OF SURVIVAL FACTOR
- 专利权人:
- ЧУГАИ СЕИЯКУ КАБУШИКИ КАИША (JP)
- 发明人:
- ЁНЕЯМА Коитиро (JP)
- 申请号：
- RU2017101705
- 公开号：
- RU2017101705A
- 申请日:
- 2015.03.31
- 申请国别(地区):
- RU
- 年份:
- 2018
- 代理人:
- 摘要：
- The inventors discovered that by administering a pharmaceutical composition comprising a bispecific antigen-binding molecule that recognizes blood coagulation factor IX and/or activated blood coagulation factor IX and blood coagulation factor X and/or activated blood coagulation factor X according to a given dosage regimen, diseases that develop and/or progress due to a decrease or deficiency in the activity of blood coagulation factor VIII and/or activated blood coagulation factor VIII can be prevented and/or treated more effectively.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
- PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
- VIII / VIII / / PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII
- Pharmaceutical composition used for the prevention and / or treatment of diseases that develop and / or develop due to decreased or deficient activity of blood coagulation factor VIII and / or activated blood coagulation VIII
- Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor Vlll and/or activated blood coagulation factor Vlll.
